文献速递自身炎症与 IgG4 相关病

血清白介素-18水平升高可区分斯蒂尔病与其他自身炎症性疾病:欧洲ImmunAID队列研究结果

Elevated serum levels of interleukin-18 discriminate Still's disease from other autoinflammatory conditions: results from the European ImmunAID cohort.
PubMed 文献 · RMD Open · 2025-05-07

该研究纳入53例单基因自身炎症性疾病、220例遗传学未确诊自身炎症性疾病患者及49例无炎症性疾病对照,检测血清IL-1β、IL-18、IL-1Ra、IL-18BP及IFN-γ水平。结果显示斯蒂尔病患者总IL-18和游离IL-18水平显著升高,总IL-18诊断斯蒂尔病的曲线下面积为0.91,游离IL-18在治疗后显著下降。

要点

  • 斯蒂尔病患者血清总IL-18和游离IL-18水平较多数其他自身炎症性疾病及对照显著升高。
  • 总IL-18诊断斯蒂尔病的ROC曲线下面积为0.91,为最敏感和特异的标志物。
  • 10例斯蒂尔病患者治疗后血清游离IL-18水平显著下降。

核心结论

  • IL-18可区分斯蒂尔病与其他自身炎症性疾病,游离IL-18水平可能有助于评估这些患者的治疗反应。

研究设计与样本

  • 建立来自不同欧洲国家的活动期自身炎症性疾病患者队列,包括单基因自身炎症性疾病和遗传学未确诊自身炎症性疾病,纳入时均为活动期。
  • 采用免疫分析法检测血清细胞因子水平。
  • 分析53例单基因自身炎症性疾病、220例遗传学未确诊自身炎症性疾病和49例无炎症性疾病对照的血清。

主要发现

  • 斯蒂尔病患者血清总IL-18和游离IL-18水平较多数其他自身炎症性疾病及无炎症对照显著升高。
  • 家族地中海热患者总IL-18水平也升高,程度与斯蒂尔病相当。
  • 游离IL-18水平仅在斯蒂尔病中选择性升高。
  • 总IL-18诊断斯蒂尔病的ROC曲线下面积为0.91。
  • IL-18与铁蛋白呈正相关;10例斯蒂尔病患者第二次采血显示治疗后血清游离IL-18水平显著下降。

关键数值与推荐

  • 总IL-18诊断斯蒂尔病的ROC曲线下面积为0.91。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic autoinflammatory diseases (SAIDs) represent a set of conditions with exaggerated innate immune responses. IL-1β and IL-18 are key cytokines involved in the pathogenesis of some SAID. We aimed to assess the diagnostic value of serum levels of IL-1β, IL-18, their respective inhibitors IL-1Ra and IL-18 binding protein (IL-18BP), and IFN-γ in SAID. METHODS: A cohort of patients with active SAID, including monogenic (mSAID) and genetically undiagnosed SAID (guSAID) from different European countries, with active disease at inclusion, was established. Serum levels of cytokines were measured by immunoassays. RESULTS: Sera from 53 mSAID, 220 guSAID and 49 controls without inflammatory disease were analysed. Serum levels of total and free IL-18 were significantly increased in Still's disease in comparison to most SAID and non-inflammatory controls. Levels of total IL-18 were also elevated in patients with familial Mediterranean fever to a comparable extent as in Still's disease. In contrast, free IL-18 levels were selectively higher in Still's disease. Receiver operating characteristic curve analysis showed that total IL-18 was the most sensitive and specific marker for the diagnosis of Still's disease (area under the curve=0.91). There was a positive correlation between IL-18 and ferritin. In 10 patients with Still's disease who had a second blood collection, we found a significant decrease in serum levels of free IL-18 after treatment. CONCLUSIONS: Our results show that IL-18 can discriminate Still's disease from other SAID, and free IL-18 levels may be relevant to assess response to therapy in these patients.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Girard-Guyonvarc'h C, Rodriguez E, Mueller YM, et al. Elevated serum levels of interleukin-18 discriminate Still's disease from other autoinflammatory conditions: results from the European ImmunAID cohort. RMD Open. 2025. PMID: 40341183. doi:10.1136/rmdopen-2024-005388

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。